Evidence map›Paper›PMID 42483212›Full record

ArticleFrontiers in cell and developmental biology2026

A human intestinal epithelial-mesenchyme-immune triple culture system for disease modelling.

Joep Korsten, Alessandro Dei, Carlemi Calitz, Nina Johannesson, Eline Freeze, Eloi Mercier, Jessica Chen, Mark Hills, Allen Eaves, Sharon Louis and 6 more

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Joep Korsten *OrganoVIR Labs, Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, Amsterdam Institute for Reproduction and Development, University of Amsterdam, Amsterdam, Netherlands.
Alessandro Dei *STEMCELL Technologies UK Ltd., Cambridge, United Kingdom.
Carlemi Calitz *OrganoVIR Labs, Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, Amsterdam Institute for Reproduction and Development, University of Amsterdam, Amsterdam, Netherlands.
Nina JohannessonOrganoVIR Labs, Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, Amsterdam Institute for Reproduction and Development, University of Amsterdam, Amsterdam, Netherlands.
Eline FreezeOrganoVIR Labs, Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, Amsterdam Institute for Reproduction and Development, University of Amsterdam, Amsterdam, Netherlands.
Eloi MercierSTEMCELL Technologies Inc., Vancouver, BC, Canada.
Jessica ChenSTEMCELL Technologies Inc., Vancouver, BC, Canada.
Mark HillsSTEMCELL Technologies Inc., Vancouver, BC, Canada.
Allen EavesSTEMCELL Technologies UK Ltd., Cambridge, United Kingdom.
Sharon LouisSTEMCELL Technologies Inc., Vancouver, BC, Canada.
Ryan K ConderSTEMCELL Technologies Inc., Vancouver, BC, Canada.
Wing ChangSTEMCELL Technologies Inc., Vancouver, BC, Canada.
Dasja PajkrtOrganoVIR Labs, Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, Amsterdam Institute for Reproduction and Development, University of Amsterdam, Amsterdam, Netherlands.
Katja C WolthersOrganoVIR Labs, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, Netherlands.
Salvatore Simmini *STEMCELL Technologies UK Ltd., Cambridge, United Kingdom.
Adithya Sridhar *OrganoVIR Labs, Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam UMC, Academic Medical Center, Amsterdam Institute for Infection and Immunity, Amsterdam Institute for Reproduction and Development, University of Amsterdam, Amsterdam, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The intestinal mucosa plays a vital role in nutrient absorption, drug metabolism, and pathogen defence. Advances in single-cell technologies have highlighted the specialised roles of various cell types that execute these diverse functions. Beyond intestinal epithelial cells, fibroblasts regulate the extracellular matrix (ECM) and modulate pro-inflammatory signalling, while antigen-presenting cells (macrophages and dendritic cells) maintain intestinal homeostasis and immune responses. However, the incorporation of such cellular complexity within existing Methods: We developed a human intestinal co-culture model that incrementally mimics the mucosal cellular environment, comprising intestinal epithelial cells, intestinal fibroblasts, and antigen-presenting cells. The model incorporated co-cultures of both adult and foetal cells to facilitate studies of intestinal development, barrier function, inflammation, and viral infections. Results: We successfully established an advanced multi-cellular intestinal co-culture model that recapitulates key features of the native mucosal environment. This model demonstrated the capacity for ECM deposition, Paneth cell differentiation, and functional immune interactions. Notably, the co-culture system effectively modelled immune responses during viral infections, demonstrating the utility of incorporating multiple cell types and developmental stages. Discussion: Our co-culture model improves the physiological relevance of in vitro studies by incorporating multi-cellular complexity previously lacking in existing systems. This advancement enables the exploration of epithelial-mesenchymal-immune crosstalk in intestinal health and disease, providing a powerful platform for studying intestinal development, barrier dysfunction, and infection-related pathology.

Indexed as

cytomegalovirusdendritic cellenterovirusgut-on-chipintestinal epithelial barrierintestine-on-chipmacrophagemesenchyme

Identifiers

PMID42483212
PMCPMC13385409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.